ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released

June 5, 1987

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003

NCI CTEP-Approved Trials For the Month of October

October 31, 2014

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

March 5, 1993

Pauling Contends His Applications Included Essentials

April 27, 1979

In Brief: NCI Registers Web Domain CANCER>GOV, Plans To Improve External Communications

October 29, 1999